Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/19056
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Pavlidis, N. A. | en |
dc.contributor.author | Elisaf, M. S. | en |
dc.contributor.author | Bai, M. | en |
dc.contributor.author | Tolis, C. | en |
dc.contributor.author | Papadimitriou, C. | en |
dc.date.accessioned | 2015-11-24T18:56:32Z | - |
dc.date.available | 2015-11-24T18:56:32Z | - |
dc.identifier.issn | 0098-1532 | - |
dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/19056 | - |
dc.rights | Default Licence | - |
dc.subject | Antineoplastic Combined Chemotherapy Protocols/therapeutic use | en |
dc.subject | Cyclophosphamide/administration & dosage | en |
dc.subject | Heart Neoplasms/*drug therapy | en |
dc.subject | Humans | en |
dc.subject | Lymphoma, B-Cell/*drug therapy | en |
dc.subject | Lymphoma, Large B-Cell, Diffuse/*drug therapy | en |
dc.subject | Male | en |
dc.subject | Middle Aged | en |
dc.subject | Pericardium | en |
dc.subject | Prednisone/administration & dosage | en |
dc.subject | Vincristine/administration & dosage | en |
dc.title | Primary lymphoma of the pericardium: report on a "cured" case and review of the literature | en |
heal.type | journalArticle | - |
heal.type.en | Journal article | en |
heal.type.el | Άρθρο Περιοδικού | el |
heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/8107663 | - |
heal.identifier.secondary | http://onlinelibrary.wiley.com/store/10.1002/mpo.2950220415/asset/2950220415_ftp.pdf?v=1&t=h0niq7ed&s=01f996bef400cba8ff0675093d667f878c319e07 | - |
heal.language | en | - |
heal.access | campus | - |
heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
heal.publicationDate | 1994 | - |
heal.abstract | This report describes a 62-year-old man with a primary diffuse, immunohistochemically proven B-cell lymphoma of large non-cleaved cell (centroblastic) type of the pericardium. The patient responded completely to systemic chemotherapy and remains free of disease 30 months after diagnosis. The use of non-cardiotoxic drugs in divided doses as initial treatment is emphasized. In addition, the authors reviewed the literature of the last decade regarding the management and outcome of patients with primary cardiac lymphomas. | en |
heal.journalName | Med Pediatr Oncol | en |
heal.journalType | peer-reviewed | - |
heal.fullTextAvailability | TRUE | - |
Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Pavlidis-1994-Primary lymphoma of.pdf | 452.72 kB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License